Kawasaki disease cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Kawasaki disease}} {{CMG}}; {{AE}} ==Overview== ==Cost-effectiveness of Therapy== ==References== {{Reflist|2}} {{WH}} {{WS}} Category: (name of the syste..." |
No edit summary |
||
Line 15: | Line 15: | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category:Pediatrics]] | ||
[[Category:Cardiovascular diseases]] | |||
[[Category:Angiology]] | |||
[[Category:Cardiology]] | |||
[[Category:Rheumatology]] | |||
[[Category:Dermatology]] | |||
[[Category:Emergency medicine]] | |||
[[Category:Up-To-Date]] |
Latest revision as of 15:57, 16 April 2018
Kawasaki disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
American Roentgen Ray Society Images of Kawasaki disease cost-effectiveness of therapy |
Risk calculators and risk factors for Kawasaki disease cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: